These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 33166547)

  • 1. A fluorescence-based high throughput-screening assay for the SARS-CoV RNA synthesis complex.
    Eydoux C; Fattorini V; Shannon A; Le TT; Didier B; Canard B; Guillemot JC
    J Virol Methods; 2021 Feb; 288():114013. PubMed ID: 33166547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase.
    Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase.
    Adedeji AO; Singh K; Calcaterra NE; DeDiego ML; Enjuanes L; Weiss S; Sarafianos SG
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4718-28. PubMed ID: 22733076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery.
    Ge F; Xiong S; Lin FS; Zhang ZP; Zhang XE
    Antiviral Res; 2008 Nov; 80(2):107-13. PubMed ID: 18584889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
    Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H
    J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.
    Elshabrawy HA; Fan J; Haddad CS; Ratia K; Broder CC; Caffrey M; Prabhakar BS
    J Virol; 2014 Apr; 88(8):4353-65. PubMed ID: 24501399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay.
    Bai X; Sun H; Wu S; Li Y; Wang L; Hong B
    Front Immunol; 2022; 13():844749. PubMed ID: 35464436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus.
    Sevajol M; Subissi L; Decroly E; Canard B; Imbert I
    Virus Res; 2014 Dec; 194():90-9. PubMed ID: 25451065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture.
    te Velthuis AJ; van den Worm SH; Sims AC; Baric RS; Snijder EJ; van Hemert MJ
    PLoS Pathog; 2010 Nov; 6(11):e1001176. PubMed ID: 21079686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA.
    Hertzig T; Scandella E; Schelle B; Ziebuhr J; Siddell SG; Ludewig B; Thiel V
    J Gen Virol; 2004 Jun; 85(Pt 6):1717-1725. PubMed ID: 15166457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery.
    Zhu W; Chen CZ; Gorshkov K; Xu M; Lo DC; Zheng W
    SLAS Discov; 2020 Dec; 25(10):1141-1151. PubMed ID: 32660307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage.
    Snijder EJ; Bredenbeek PJ; Dobbe JC; Thiel V; Ziebuhr J; Poon LL; Guan Y; Rozanov M; Spaan WJ; Gorbalenya AE
    J Mol Biol; 2003 Aug; 331(5):991-1004. PubMed ID: 12927536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates.
    Ahn DG; Choi JK; Taylor DR; Oh JW
    Arch Virol; 2012 Nov; 157(11):2095-104. PubMed ID: 22791111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicases as antiviral drug targets.
    Huang JD; Zheng BJ; Sun HZ
    Hong Kong Med J; 2008 Aug; 14 Suppl 4():36-8. PubMed ID: 18708673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture.
    Shema Mugisha C; Vuong HR; Puray-Chavez M; Bailey AL; Fox JM; Chen RE; Wessel AW; Scott JM; Harastani HH; Boon ACM; Shin H; Kutluay SB
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32878932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of SARS-CoV entry--identification using an internally-controlled dual envelope pseudovirion assay.
    Zhou Y; Agudelo J; Lu K; Goetz DH; Hansell E; Chen YT; Roush WR; McKerrow J; Craik CS; Amberg SM; Simmons G
    Antiviral Res; 2011 Nov; 92(2):187-94. PubMed ID: 21820471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach.
    Aftab SO; Ghouri MZ; Masood MU; Haider Z; Khan Z; Ahmad A; Munawar N
    J Transl Med; 2020 Jul; 18(1):275. PubMed ID: 32635935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors.
    Luo Y; Yu F; Zhou M; Liu Y; Xia B; Zhang X; Liu J; Zhang J; Du Y; Li R; Wu L; Zhang X; Pan T; Guo D; Peng T; Zhang H
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.